A potential melanoma tracer: Synthesis, radiolabeling, and biodistribution in mice of a new nitridotechnetium bis(aminothiol) derivative pharmacomodulated by a N-(diethylaminoethyl)benzamide

Journal of Medicinal Chemistry

Volumn 43, Issue 2, 2000, Pages 190-198

  Auzeloux, Philippe ^a   Papon, Janine ^a   Azim, El Mostapha ^a   Borel, Michèle ^a   Pasqualini, Roberto ^b   Veyre, Annie ^a   Madelmont, Jean Claude ^a  

^a INSERM   (France)

^b CIS Bio International   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; NITRIDOTECHNETIUM BIS(AMINOTHIOL); RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG UPTAKE; ISOTOPE LABELING; MELANOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REACTION ANALYSIS; SPECTROSCOPY;

ANIMALS; BENZAMIDES; BLOOD-BRAIN BARRIER; KIDNEY; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; ORGANOTECHNETIUM COMPOUNDS; TISSUE DISTRIBUTION;

EID: 0034719436     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm981089a     Document Type: Article

References (43)

1. Osterlind, A. Epidemiology on malignant melanoma in Europe. Rev. Oncol. 1992, 5, 903.
2. Burton, R. C.; Coates, M. S.; Hersey, P.; Roberts, G.; Chetty, P. P.; Chen, S.; Hayes, M. H.; Howe, C. G.; Armstrong, B. K. An analysis of a melanoma epidemic. Int. J. Cancer 1993, 55, 765-770.
3. Hill, C.; Koscielny, S.; Doyon, F.; Benhamou, E. Evolution de la mortalité par cancer en France 1950-1990; Les éditions INSERM: Paris, 1993.
4. Mackie, R. M. The march of melanoma. Clin. Exp. Dermatol. 1993, 18, 2.
5. Boyle, P.; Maisonneuve, P.; Doré, J. F. Epidemiology of malignant melanoma. Br. Med. Bull 1995, 51, 523-547.
6. Hill, C.; Doyon, F. La mortalité par cancer en France. Med. Sci. 1997, 13, 172-175.
7. Michelot, J. M.; Moreau, M. F. C.; Labarre, P. G.; Madelmont, J. C.; Veyre, A. J.; Papon, J. M.; Parry, D. F.; Bonafous, J. F.; Boire, J. Y. P.; Desplanches, G. G.; Bertrand, S. J.; Meyniel, G. Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J. Nucl. Med. 1991, 32, 1573-1580.
8. Moreau, M. F.; Michelot, J.; Veyre, A.; Madelmont, J. C.; Godenèche, D.; Labarre, P.; Parry, D.; Meyniel, G. Agents pour le diagnostic et le traitement des mélanomes, dérivés halogénés aromatiques utilisables comme de tels agents et leur préparation. French patent 890 1898, Feb 14, 1989.
9. 125I-radiopharmaceuticals for diagnosis and treatment for malignant melanoma. Eur. J. Nucl. Med. 1993, 18, 538.
10. Moreau, M. F.; Michelot, J.; Papon, J.; Bayle, M.; Labarre, P.; Madelmont, J. C.; Parry, D.; Boire, J. Y.; Seguin, H.; Veyre, A.; Mauclaire, L. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents. Nucl. Med. Biol. 1995, 22, 737-747.
11. 123I-BZA. Melanoma Res. 1993, 3, 83.
12. Michelot, J. M.; Moreau, M. F. C.; Veyre, A. J.; Bonafous, J. F.; Bacin, F. J.; Madelmont, J. C.; Bussiere, F.; Souteyrand, P. A.; Mauclaire, L. P.; Chossat, F. M.; Papon, J. M.; Labarre, P. G.; Kauffman, Ph.; Plagne, R. J. Phase II scintigraphic clinic trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl-4-iodobenzamide). J. Nucl. Med. 1993, 34, 1260-1266.
13. Nicholl, C.; Mohammed, A.; Hull, W. E.; Bubeck, B.; Eisenhut, M. Pharmacokinetics of iodine-123-IMBA for melanoma imaging. J. Nucl. Med. 1997, 38, 127-133.
14. John, C. S.; Lim, B. B.; Vilner, B. J.; Geyer, B. C.; Bowen, W. D. Substitued halogenated arylsulfonamides: a new class of σ receptor binding tumor imaging agents. J. Med. Chem. 1998, 41, 2445-2450.
15. John, C. S.; Bowen, W. D.; Saga, T.; Kinuya, S.; Vilner, B. J.; Baumgold, J.; Paik, C. H.; Reba, R. C.; Neuman, R. D.; Varma, V. M.; McAfee, J. G. A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide. J. Nucl. Med. 1993, 34, 2169-2175.
16. Efange, S. M.; Michelson, R. H.; Knusel, B.; Hefti, F.; Boudreau, R. J.; Thomas, J. R.; Tennison, J. R. Synthesis and biological evaluation of radioiodinated N-2-(4-piperidyl)ethyl benzamides. Nucl. Med. Biol. 1993, 20, 527-538.
17. Vilner, B. J.; John, C. S.; Bowen, W. D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 1995, 55, 408-413.
18. Chehade, F.; Michelot, J.; Hindie, E.; Papon, J.; Delabriolle-Vaylet, C.; Zhang, L.; Escaig, F.; Moreau, M. F.; Veyre, A. Localization of N-(2-diethylaminoethyl)-4-iodobenzamide in the pigmented mouse eye: a microanalytical study. Cell. Mol. Biol. 1998, 42, 343-350.
19. 123, 131I]iodobenzamides by animal and cell-culture studies. J. Labelled Compd. Radiopharm. 1995, 37, 260-262.
20. Dittman, H.; Coenen, H. H.; Zölzer, P.; Dutschka, K.; Brandau, W.; Streffer, C. In vitro studies on the cellular uptake of melanoma imaging aminoalkyl-iodobenzamide derivatives (ABA). Nucl. Med. Biol. 1999, 26, 51-56.
21. Nicholl, C.; Mohammed, A.; Eisenhut, M. Dialkylaminoalkyl-4-iodobenzamides: Influence of specific activity and substituents on melanoma uptake and biodistribution. J. Labelled Compd. Radiopharm. 1995, 37, 277-279.
22. Jurisson, S. S.; Lydon, J. D. Potential technetium small molecule radiopharmaceuticals. Chem. Rev. 1999, 99, 2205-2218.
23. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem. Rev. 1999, 99, 2235-2268.
24. Hom, R. K.; Katzenellengogen, J. A. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results. Nucl. Med. Biol. 1997, 24, 485-498.
25. Epps, L. A.; Kramer, A. V.; Burns, H. D.; Zemyan, S. E.; Dannals, R. F.; Goldfarb, H.; Ravert, H. Synthesis and characterization of a neutral oxotechnetium(V)diaminothiol complex. J. Nucl. Med. 1983, 24, P10.
26. 99mTc nitrido tumor imaging disposition in mice. Appl. Radiat. Isot. 1992, 43, 425-436.
27. 99mTc brain agents. J. Med. Chem. 1985, 28, 1280-1284.
28. Lipton, M. F.; Basha, A.; Weinreb, M. Conversion of esters to amides with dimethylaluminium amides: N,N-dimethylcyclohexanecarboxamide. Organic syntheses; John Wiley & Sons: New York, 1988; Vol. 6, pp 492-495.
29. Joshua, A. V.; Scott, J. R.; Sondhi, S. M.; Ball, R. G.; Lown, J. W. Transannular cyclisation of 1,2-dithia-5,8-diazacyclodeca-4,8-dienes during borohydride reduction. J. Org. Chem. 1987, 52, 2447-2451.
30. Lever, S. Z.; Sun, S.-Y.; Kaltovich, F.; Scheffel, U.; Goldfarb, H.; Mahmood, A.; Baidoo, K. E.; Wagner, H. N. Jr. Pulmonary accumulation of neutral alkyl-DADT-technetium complexes: Structure-biodistribution relationships. J. Nucl. Med. 1988, 5, 789.
31. Shiba, K.; Mori, H.; Matsuda, H.; Tsuji, S.; Kinuya, K.; Hisada, K.; Synthesis of technetium-99m labeled diaminodithiol for bifunctional chelating agent. Appl. Radiat. Isot. 1991, 42, 1159-1164.
32. 99mTc-glucoheptonate and N-benzyl-N-methylpiperazinyl-bis-(aminoethanethiol) (BPA-BAT). Appl. Radiat. Isot. 1989, 40, 677-681.
33. 99mTc-TMR for brain imaging. Nucl. Med. Biol. 1989, 16, 829-837.
34. 99mTc-bis (aminoethanethiol) complexes. Nucl. Med. Biol. 1989, 16, 805-811.
35. Duatti, A.; Marchi, A.; Pasqualini, R. A new method for the preparation of Tc-99m radiopharmaceuticals containing the Tc≡ N multiple bond. Eighth international symposium on radiopharmaceutical chemistry abstracts. J. Labelled Compds. Radiopharm. 1991, 30, 13.
36. 99mTc-radiopharmaceuticals containing Tc≡N multiple bond. Appl. Radiat. Isot. 1992, 43, 1329-1333.
37. 99mTc≡N multiple bond. In Technetium and Rhenium in Chemistry and Nuclear Medicine; Nicolini, M., Bandoli, G., Mazzi, U., Eds.; SGE Ditoriali: Padova. Italy, 1995; Vol. 4, pp 113-116.
38. Baldas, J.; Boas, J. F.; Bonnyman, J.; Williams, G. A. Studies of technetium complexes. Part 6. The preparation, characterisation, and electron spin resonance spectra of salts of tetrachloroand tetrabromo-nitridotechnetate(vi): crystal structure of tetraphenyl-arsonium tetrachloro-nitridotechnetate(vi). J. Chem. Soc., Dalton Trans. 1984, 2395-2400.
39. Francesconi, L. C.; Yang, Y. Y.; Kung, M.-P.; Zhang, X. X.; Billings, J.; Guo, Y. Z.; Kung, H. F. Technetium-99m N,N′-bis-(2-mercapto-2-methylpropyl)-2-aminobenzylamine: technetium-99m complexes of a novel bis(aminoethanethiol) ligand. J. Med. Chem. 1994, 37, 3282-3288.
40. Colmanet, S. F.; Williams, G. A. Structural aspects of technetium nitrido complexes. In Technetium and Rhenium in Chemistry and Nuclear Medicine; Nicolini, M., Bandoli, G., Mazzi, U., Eds.; Cortinal International-Verona Raven Press: New York, 1990; Vol. 3, pp 55-62.
41. Duatti, A.; Marchi, A.; Pasqualini, R. Formation of the Tc=N multiple bond from the reaction of ammonium pertechnetate with S-methyl dithiocarbazate and its application to the preparation of technetium-99m radiopharmaceuticals. J. Chem. Soc., Dalton Trans. 1990, 3729-3733.
42. 2 ligands: Synthesis and crystal structures. J. Chem. Soc., Dalton Trans. 1992, 1485-1492.
43. - analogues which contain 5,5,5-membered chelate ring systems. J. Med. Chem. 1992, 35, 274-279.